Quarterly ResultMay 7, 2026, 04:10 PM
EDAP TMS Q1 Revenue +24.8% to $17.8M; Net Loss $(9.1)M
AI Summary
EDAP TMS SA reported a 24.8% increase in total revenues to $17.8 million for the first quarter of 2026, driven by growth across its HIFU, ESWL, and Distribution segments. Despite the revenue growth and a 35.9% rise in gross profit, the company's net loss widened to $(9.1) million, resulting in a diluted loss per share of $(0.24). Cash and cash equivalents decreased to $15.0 million, but the company subsequently secured additional liquidity by drawing €12.0 million from its EIB credit facility in April 2026.
Key Highlights
- Total revenues increased by 24.8% to $17.8 million for Q1 2026, up from $14.3 million in Q1 2025.
- Gross profit rose by 35.9% to $8.1 million in Q1 2026, compared to $6.0 million in Q1 2025.
- Net loss for Q1 2026 was $(9.1) million, an increase from $(7.4) million in Q1 2025.
- Basic and diluted loss per share was $(0.24) in Q1 2026, compared to $(0.20) in Q1 2025.
- Cash and cash equivalents decreased to $15.0 million as of March 31, 2026, from $20.5 million at December 31, 2025.
- HIFU division sales totaled $11.6 million, ESWL division sales were $1.5 million, and Distribution division sales reached $4.7 million in Q1 2026.
- Subsequent to quarter-end, EDAP TMS drew Tranche B of its EIB credit facility for €12.0 million ($12.8 million) on April 20, 2026.
- The company issued 1,116,244 Tranche B Warrants to EIB with a strike price of €3.23 per share.
- Long-term debt, non-current, increased to $17.6 million as of March 31, 2026, from $15.9 million at December 31, 2025.